| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 12/12/2007 | CN101085143A Traditional Chinese medicine composition for treating dysmenorrhoea |
| 12/12/2007 | CN101085142A Traditional Chinese medicine preparation for treating dysmenorrhoea |
| 12/12/2007 | CN101085131A Internal-applied traditional Chinese medicine for treating rigid spine inflammation |
| 12/12/2007 | CN101085110A Scorpion extraction liquid |
| 12/12/2007 | CN101085109A Traditional Chinese medicine composition of scorpion health-care wine |
| 12/12/2007 | CN101085093A Spray agent for rheumatism and soft tissue damage |
| 12/12/2007 | CN101085078A Exterior-applied medicine liquid for treating osteoarthrilis |
| 12/12/2007 | CN101085063A Medicine plaster for treating dysmenorrhea |
| 12/12/2007 | CN101085036A Porridge with blood-activating and qi-promoting function |
| 12/12/2007 | CN101085035A Porridge containing ligusticum wallichii and red sage root |
| 12/12/2007 | CN101084989A Method for preparing general flavone and total alkaloid of sophora flavescens simultaneously |
| 12/12/2007 | CN101084971A Method for preparing total saponins of platycodon grandiflorum |
| 12/12/2007 | CN101084963A Porridge containing notoginseng with hemostatic function |
| 12/12/2007 | CN101084951A Medicine for treating diseases concerned with respiratory and preparation method and application thereof |
| 12/12/2007 | CN101084949A Bupleurum Chinense volatile oil percutaneous controlled-release plaster and preparation method thereof |
| 12/12/2007 | CN101084948A Method for preparing saikosaponin |
| 12/12/2007 | CN101084945A Olive leaves extraction and preparation method thereof |
| 12/12/2007 | CN101084911A Notoginsenoside sodium freezing-dried emulsion and preparation method thereof |
| 12/12/2007 | CN101084910A Glucocorticoid synergist |
| 12/12/2007 | CN101084894A Medicine for treating diseases concerned with respiratory and use thereof |
| 12/12/2007 | CN100354277C 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 12/12/2007 | CN100354273C Novel substituted 4-phenyl-4-ú¿1h-imidazol-2-ylú®-piperidine derivatives and their use as selective non-peptide delta opioid agonists |
| 12/12/2007 | CN100354000C Use of alpha-1 antitrypsin for the preparation of medicaments for the treatment of fibromyalgia |
| 12/12/2007 | CN100353980C Freeze-dried 'Shengmai' powder for injection and its preparing process |
| 12/12/2007 | CN100353977C Preparation method and formula of moxibustion ramee strip with muskiness |
| 12/12/2007 | CN100353962C Medicine composition for curing inflammatory bone disease and process for preparing the same |
| 12/12/2007 | CN100353959C Navel plastering piece for treating dysmenorrhea and preparing method |
| 12/12/2007 | CN100353957C Chinese medicinal herb composition for treating rheumatism |
| 12/12/2007 | CN100353941C Medicinal composition contg. isoandrographolide and its medicinal use |
| 12/12/2007 | CN100353936C Ferulaic acid sodium transfusion and prescription and preparation thereof |
| 12/11/2007 | US7307164 β-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 12/11/2007 | US7307090 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 12/11/2007 | US7307080 Nuclear enzyme poly(adenosine 5'-diphospho-ribose) polymerase inhibitors; protection against ill effects of reactive free radicals and nitric oxide |
| 12/11/2007 | US7307069 Inflammatory diseases and cancers; promotion of apoptosis; may have phosphorothioate, 2'-O-(2-methoxyethyl) sugar, and/or 5-methyl cytosine modifications; useful prophylactically, and as clinical research and diagnostic tools. |
| 12/11/2007 | US7306903 Use of test cells comprising DNA defining a morphogen-responsive transcription activating element operatively associated with reporter gene, increase in expression of detectable gene product after exposing test cell to candidate compound indicates ability of compound to induce morphogen-mediated effect |
| 12/11/2007 | US7306783 Complexing; drug delivery; in situ imaging; detection apoptosis |
| 12/11/2007 | CA2348735C Heterocyclic potassium channel inhibitors |
| 12/11/2007 | CA2184077C Nasal and ocular administration of ketamine to manage pain and for detoxification |
| 12/06/2007 | WO2007140439A2 Compounds as cannabinoid receptor ligands and uses thereof |
| 12/06/2007 | WO2007139921A2 N-oxides of kappa opioid receptor peptides |
| 12/06/2007 | WO2007139813A1 Imidazoazephinone compounds |
| 12/06/2007 | WO2007139795A1 Thiophene-carboxamides useful as inhibitors of protein kinases |
| 12/06/2007 | WO2007139496A1 Quinoline derivatives acting as tyrosine kinase inhibitors |
| 12/06/2007 | WO2007139230A1 Seven-membered ring compound, production method thereof and pharmaceutical use thereof |
| 12/06/2007 | WO2007139211A1 Process for production of optically active piperidine compound |
| 12/06/2007 | WO2007139164A1 Humanized anti-human osteopontin antibody |
| 12/06/2007 | WO2007139128A1 Composition for inhibiting the secretion of creatine phosphokinase |
| 12/06/2007 | WO2007138997A1 Oral composition comprising 3-[5-[4-(cyclopentyloxy) -2-hydroxybenzoyl]-2-[(3-hydroxy-1,2-benzisoxazol-6- yl)methoxy]phenyl]propionic acid or salt thereof |
| 12/06/2007 | WO2007138994A1 Hsp90 inhibitor |
| 12/06/2007 | WO2007138961A1 Prophylactic or therapeutic agent for disorder induced by macrophage migration inhibitory factor |
| 12/06/2007 | WO2007138072A2 Triazolopyrazine compounds useful for the treatment of degenerative & inflammatory diseases |
| 12/06/2007 | WO2007121917A3 Purine derivatives as adenosine receptor activator |
| 12/06/2007 | WO2007107869A3 Lipid derivatives |
| 12/06/2007 | WO2007107828A3 Amine derivatives |
| 12/06/2007 | US20070282100 Boronic ester and acid compounds, synthesis and uses |
| 12/06/2007 | US20070282095 Thrombin Derivatives And Medicinal Composition Containing The Same |
| 12/06/2007 | US20070281944 Non-peptide bradykinin antagonists and pharmaceutical compositions therefrom |
| 12/06/2007 | US20070281938 Inhibitors of 11-Beta-Hydroxy Steroid Dehydrogenase Type 1 |
| 12/06/2007 | US20070281933 Novel Indazole Carboxamides And Their Use |
| 12/06/2007 | US20070281931 Pharmaceutical Composition Containing a P2x7 Receptor Antagonist and Methotrexate |
| 12/06/2007 | US20070281919 Aminothiazole Derivatives And Their Use As CRF Receptor Ligands |
| 12/06/2007 | US20070281903 Morinda Citrifolia-Based Formulation 5-LOX And 15-LOX |
| 12/06/2007 | US20070281893 Polysulfated Glycosides And Salts Thereof |
| 12/06/2007 | US20070281048 Coffee Cherry Compositions and Methods |
| 12/06/2007 | US20070281030 Non-Lamellar Compositions of Dope and P80 |
| 12/06/2007 | US20070280971 Phosphodiesterase type IV (PDE4) inhibitor; 4-{[1-(aminocarbonyl)-4-piperidinyl]amino}-N-[(3,4-dimethylphenyl)methyl]-1-ethyl-1H-pyrazolo[3,4-b]pyridine-5-carboxamide; inflammatory and/or allergic diseases such as atopic dermatitis |
| 12/06/2007 | US20070280950 Inflammatory Cytokine Inhibitors |
| 12/06/2007 | US20070280931 Antibody variants |
| 12/06/2007 | CA2653667A1 7-membered ring compound and method of production and pharmaceutical application thereof |
| 12/06/2007 | CA2653661A1 Humanized anti-human osteopontin antibody |
| 12/06/2007 | CA2653506A1 Triazolopyrazine compounds useful for the treatment of degenerative & inflammatory diseases |
| 12/06/2007 | CA2653319A1 Hsp90 inhibitor |
| 12/06/2007 | CA2653077A1 N-oxides of kappa opioid receptor peptides |
| 12/06/2007 | CA2653023A1 Oral composition comprising 3-[5-[4-(cyclopentyloxy) -2-hydroxybenzoyl]-2-[(3-hydroxy-1,2-benzisoxazol-6-yl)methoxy]phenyl]propionic acid or sa lt thereof |
| 12/06/2007 | CA2653005A1 Thiophene-carboxamides useful as inhibitors of protein kinases |
| 12/06/2007 | CA2651454A1 Imidazoazephinone compounds |
| 12/06/2007 | CA2647598A1 Compounds as cannabinoid receptor ligands and uses thereof |
| 12/06/2007 | CA2647597A1 Thiazole compounds as cannabinoid receptor ligands and uses thereof |
| 12/05/2007 | EP1862475A1 Polymer conjugates of neublastin and methods of using same |
| 12/05/2007 | EP1862457A2 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 12/05/2007 | EP1862454A1 Novel compounds, isomer thereof or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and a pharmaceutical composition containing the same |
| 12/05/2007 | EP1862451A1 Adamantane derivatives for the treatment of inflammatory diseases |
| 12/05/2007 | EP1862444A2 Ether compounds, compositions, and uses thereof |
| 12/05/2007 | EP1861404A1 Polymorphic form of 6- (4-chlorophenyl) -2, 2-dimethyl-7-phenyl-2, 3-dihydro-lh-pyrrolizin-5-ylacetic acid |
| 12/05/2007 | EP1861403A1 Novel imidazo[1,5-a]pyridine derivatives, method for preparing same and pharmaceutical compositions containing same |
| 12/05/2007 | EP1861402A1 Isoflavonoid dimers |
| 12/05/2007 | EP1861387A1 Novel benzoimidazole derivatives and pharmaceutical composition comprising the same |
| 12/05/2007 | EP1861377A1 Benzimidazolone derivatives as cb2 receptor ligands |
| 12/05/2007 | EP1861371A1 Novel compounds ii 2-pyridine derivatives as inhibitors of neutrophile elastase. |
| 12/05/2007 | EP1861370A1 2-pyridine derivatives as inhibitors of neutrophile elastase |
| 12/05/2007 | EP1861359A1 N-(n-sulfonylaminomethyl)cyclopropanecarboxamide derivatives useful for the treatment of pain |
| 12/05/2007 | EP1861100A1 3 , llB-CIS-DIHYDROTETRABENAZINE FOR THE TREATMENT OF A PROLIFERATIVE DISEASE OR AN INFLAMMATION |
| 12/05/2007 | EP1861099A2 Combination of a steroid sulfatase inhibitor and an ascomycin |
| 12/05/2007 | EP1861098A1 Anti-inflammatory compounds |
| 12/05/2007 | EP1861090A1 Anti-inflammatory modalities |
| 12/05/2007 | EP1861072A2 Nanocells for diagnosis and treatment of diseases and disorders |
| 12/05/2007 | EP1860942A2 Bicycloheteroaryl compounds as p2x7 modulators and uses thereof |
| 12/05/2007 | EP1720848B1 Derivatives of alkylpiperazine- and alkylhomopiperazine- carboxylates, preparation method thereof and use of same as faah enzyme inhibitors |
| 12/05/2007 | EP1399420B1 Pyrrolidines as dipeptidyl peptidase inhibitors |
| 12/05/2007 | EP1368318B1 Calcilytic compounds |